Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | BID | P55957 | 3/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.35 |
| ▸ | BAK1 | Q16611 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4690988 | 1.00 | HIF1A (0.39) | HIF1ACYP1A2CYP3A4TSHRCYP2C9 | |
| Bromide SCHEMBL9623514 | 0.93 | SOAT2 (0.46) | CYP3A4TSHRALDH1A1SOAT2SOAT1 | |
| Bromide SCHEMBL9623511 | 0.93 | SOAT2 (0.46) | CYP3A4TSHRALDH1A1SOAT2SOAT1 | |
| Hydrochloric Acid SCHEMBL11497139 | 0.90 | SOAT2 (0.46) | CYP3A4TSHRALDH1A1SOAT2SOAT1 | |
| Hydrochloric Acid SCHEMBL11497137 | 0.90 | SOAT2 (0.46) | CYP3A4TSHRALDH1A1SOAT2SOAT1 | |
| Bromide SCHEMBL9594082 | 0.89 | HIF1A (0.46) | HIF1ACYP1A2TSHRCYP2C19ALDH1A1 | |
| Bromide SCHEMBL9594079 | 0.89 | HIF1A (0.46) | HIF1ACYP1A2TSHRCYP2C19ALDH1A1 | |
| Formic Acid SCHEMBL11491854 | 0.84 | SOAT2 (0.45) | SOAT2SOAT1EPHX2FAAHDAGLA | |
| Formic Acid SCHEMBL11491853 | 0.84 | SOAT2 (0.45) | SOAT2SOAT1EPHX2FAAHDAGLA | |
| Phosphoric Acid SCHEMBL11482123 | 0.84 | SOAT2 (0.45) | SOAT2SOAT1EPHX2FAAHDAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1603874-B1 | G-LACTAM DERIVATIVES AS PROSTAGLANDIN AGONISTS | SERONO LAB (CH) | 2008-05-07 | — | — | EP | disclosed |
| US-7276531-B2 | G-lactam derivatives as prostaglandin agonists | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2007-10-02 | — | — | US | disclosed |
| US-20060194865-A1 | G-lactam derivatives as prostaglandin agonists | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) | 2006-08-31 | — | — | US | disclosed |
| EP-1603874-A2 | G-LACTAM DERIVATIVES AS PROSTAGLANDIN AGONISTS | Applied Research Systems ARS Holding N.V. (AN) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004078103-A2 | G-LACTAM DERIVATIVES AS PROSTAGLANDIN AGONISTS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2004-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194865-A1 | G-lactam derivatives as prostaglandin agonists | PTGIS, PTGIR, PTGES | HIF1A 2643/4885CYP1A2 280/4885CYP3A4 481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.